Contraindication

Dogs and cats:

• Do not use in animals with heart, liver or kidney disease or gastrointestinal problems where there is a possibility of gastrointestinal ulceration or bleeding, or if there is hypersensitivity to carprofen or any other NSAID or to any of the excipients in this veterinary medicinal product.
• Do not administer by intramuscular injection.
• Do not use after surgery involving significant blood loss.
• Do not use for repeated administration in cats.
• Do not use in cats under 5 months of age.
• Do not use in dogs under 10 weeks of age.
• Do not use in dogs and cats during pregnancy or lactation.

Dosage

Carprosol 50 mg/ml is a solution for injection, for intravenous or subcutaneous use.

Dogs:

• 4 mg/kg (1 ml/12.5 kg) body weight preferably administered preoperatively, either at the time of premedication or at the induction of anaesthesia. To prolong the analgesic and anti-inflammatory effect postoperatively, parenteral treatment may be followed by 4 mg/kg/day carprofen as a tablet for up to 5 days.

Cats:

• 4 mg/kg (0.08 ml/1.0 kg) body weight preferably administered preoperatively, either at the time of premedication or at the induction of anaesthesia. The use of a 1ml graduated syringe is recommended to measure the dose accurately. Parenteral treatment should not be followed by treatment with carprofen tablets.

Composition

One ml contains:

Carprofen 50 mg

Benzyl alcohol (E1519) 15 mg

Carprosol 50 mg/ml is available in a 20 ml vial.

Side effects

Dogs and cats:

As with other NSAIDs, there is a risk of rare renal or idiosyncratic hepatic adverse reactions. Adverse reactions characteristic of NSAID use such as vomiting, soft faeces/diarrhoea, occult blood in faeces, loss of appetite and lethargy have been reported. These side effects generally occur within the first week of treatment. In most cases they are transient in nature and disappear after the end of treatment. In very rare cases, however, they can be serious or fatal.

In case of adverse reactions, discontinue use of the veterinary medicinal product and consult a veterinarian. Occasionally, reactions at the injection site may be observed after subcutaneous injection. The frequency of side effects is defined as follows:

• Very common (more than 1 in 10 animals treated show side effect(s))
• Common (more than 1 but less than 10 out of 100 animals treated)
• Uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
• Rare (more than 1 but less than 10 animals in 10,000 animals treated)
• Very rare (less than 1 in 10,000 animals treated, including isolated reports)

If you notice any side effects, even those not listed in this leaflet, or you suspect that the veterinary medicinal product is ineffective, please inform your veterinarian.

Leaflet

Download the leaflet.

FAQ